Johann Foloppe, et al.
International Oncolytic Virus Conference, April 2018
Download the poster here
Poster Presentation
TG6002: a novel oncolytic and vectorized gene-prodrug therapy approach to treat glioblastoma
By alcyon|2019-07-01T16:47:54+02:00April 17th, 2018|Publication, TG6002|Comments Off on TG6002: a novel oncolytic and vectorized gene-prodrug therapy approach to treat glioblastoma
About the Author: alcyon
Related Posts
- TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity
TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) Human Papilloma Virus (HPV)-16+ cancers: clinical efficacy and immunogenicity